Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05956535 · ClinicalTrials.gov registry record
Air Optix® Night and Day® Aqua Therapeutic Wear
A clinical trial, sponsored by Alcon Research.
- Completed
- Registry status
- 168
- Enrollment target
NCT05956535 is a clinical trial that has completed, run by Alcon Research. The registered enrollment target is 168 participants.
The verdict
NCT05956535 has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- 168 participants
- Enrollment target
Study Summary
The purpose of this study is to support the safety and performance assessment of Air Optix Night and Day Aqua (AONDA) soft contact lenses for therapeutic use in accordance with updated EU Medical Device Regulation (MDR) requirements.
Interventions
- DEVICE Balafilcon A contact lenses
- DEVICE Lotrafilcon A contact lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 2023-09-26 |
| Est. Completion | 2024-10-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05956535
The ClinicalTrials.gov registry entry for NCT05956535 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Balafilcon A contact lenses is the first listed.
NCT05956535 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05956535 about?
NCT05956535 is a clinical study titled "Air Optix® Night and Day® Aqua Therapeutic Wear". The purpose of this study is to support the safety and performance assessment of Air Optix Night and Day Aqua (AONDA) soft contact lenses for therapeutic use in accordance with updated EU Medical Device Regulation (MDR) requirements.
What is the current status of trial NCT05956535?
This trial is currently completed. The enrollment target is 168 participants. The study started on 2023-09-26. Estimated completion is 2024-10-25.
What interventions are being tested in trial NCT05956535?
The interventions under investigation include: Balafilcon A contact lenses (DEVICE), Lotrafilcon A contact lenses (DEVICE).
Who is sponsoring clinical trial NCT05956535?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.